Abstract
Measles remains an important cause of pediatric morbidity and mortality in developing countries, especially among infants who are too young to receive the current licensed live attenuated measles vaccine. We developed two Sindbis virus DNA vaccines encoding the measles virus hemagglutinin (pMSIN-H) and fusion proteins (pMSINH-FdU) and examined their immunogenicities and protective efficacies when administered alone or followed by the live measles virus vaccine in cotton rats. Neutralizing antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and gamma interferon-secreting T cells developed after priming and increased after boosting. pMSIN-H priming conferred 100% protection against pulmonary measles, whereas pMSINH-FdU protected only in conjunction with the live measles virus vaccine boost.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies, Viral / blood
-
Antibodies, Viral / immunology
-
Antibody-Producing Cells / immunology
-
Cytokines / immunology
-
Hemagglutinins, Viral / genetics
-
Hemagglutinins, Viral / immunology
-
Humans
-
Immunity, Mucosal
-
Immunization, Secondary
-
Immunologic Memory
-
Interferon-gamma / metabolism
-
Lung / immunology
-
Lung / virology
-
Measles / prevention & control*
-
Measles Vaccine / genetics
-
Measles Vaccine / immunology*
-
Measles virus / genetics
-
Measles virus / immunology*
-
Neutralization Tests
-
Rats
-
Sigmodontinae
-
Sindbis Virus / genetics*
-
Vaccines, DNA / genetics
-
Vaccines, DNA / immunology*
-
Viral Fusion Proteins / genetics
-
Viral Fusion Proteins / immunology
Substances
-
Antibodies, Viral
-
Cytokines
-
Hemagglutinins, Viral
-
Measles Vaccine
-
Vaccines, DNA
-
Viral Fusion Proteins
-
hemagglutinin protein G, measles virus
-
Interferon-gamma